Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Ro 16-0521 MeSH Supplementary Concept Data 2025


MeSH Supplementary
Ro 16-0521
Unique ID
C049434
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C049434
Entry Term(s)
1-(6-bromo-5-(o-chlorophenyl)-2,3-dihydro-1,3-dimethyl-2-oxo-1H-1,4-benzodiazepin-7-yl)-3-(1,1-bis(hydroxymethyl)ethyl)urea
Ro-16-0521
Registry Numbers
87646-83-1
CAS Type 1 Name
Urea, N-(6-bromo-5-(2-chlorophenyl)-2,3-dihydro-1,3-dimethyl-2-oxo-1H-1,4-benzodiazepin-7-yl)-N'-(2-hydroxy-1-(hydroxymethyl)-1-methylethyl)-, (S)-
Heading Mapped to
*Benzodiazepines
Frequency
3
Source
Atherosclerosis 1986;60(3):263
Date of Entry
1986/07/17
Revision Date
2001/02/07
Ro 16-0521 Preferred
1-(6-bromo-5-(o-chlorophenyl)-2,3-dihydro-1,3-dimethyl-2-oxo-1H-1,4-benzodiazepin-7-yl)-3-(1,1-bis(hydroxymethyl)ethyl)urea Broader
page delivered in 0.007s